Evidence map›Paper›PMID 31432795›Full record

ArticleIET nanobiotechnology2019

Putative mechanism for anticancer properties of Ag-PP (NPs) extract.

Masoud Homayouni-Tabrizi, Mozhgan Soltani, Ehsan Karimi, Farideh Namvar, Vahid Pouresmaeil, Ali Es-Haghi

Abstract read
In one paragraph

Article in IET nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masoud Homayouni-TabriziDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran. mhomayouni6@gmail.com.
Mozhgan SoltaniDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Ehsan KarimiDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Farideh NamvarMashhad Branch, Islamic Azad University, Mashhad, Iran.
Vahid PouresmaeilDepartment of Biochemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Ali Es-HaghiDepartment of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most important challenges in treating cancer is the invasion and the angiogenesis of cancer cells. The synthesis of green nanoparticles (NPs) and their use in therapeutic fields is one of the most effective methods with minimal side effects in cancer treatment. In this study, cytotoxic and anti-angiogenic effects of silver NPs (AgNPs) coated with palm pollen extract [Ag-PP(NPs)] were evaluated. For this purpose, the cells were treated with NPs and then were subjected to trypan blue testing (48 h). Then, the cancer invasion was evaluated by the scratch procedure and the expressions of the vascular endothelial growth factor (VEGF) and its receptor (VEGF-R) genes were estimated using real-time PCR assay. Also, the angiogenesis effect of the NPs was investigated with chick chorioallantoic membrane (CAM) assay. The Ag-PP(NPs) induced cytotoxicity on MCF7 cells. The findings also showed that Ag-PP(NPs) inhibit invasive cancer cells and reduce the expression of VEGF and VEGF-R and significantly reduced the number and vessels lengths and the lengths and weights of the embryos in CAM assay. Ag-PP(NPs) with the induction of cytotoxic effects, metastatic inhibition and anti-angiogenesis properties should be considered as an appropriate option for treatment of cancer.

Indexed as

Metal NanoparticlesAngiogenesis InhibitorsAnimalsAntineoplastic AgentsApoptosisChick EmbryoChorioallantoic MembraneDrug Evaluation, PreclinicalGene Expression Regulation, NeoplasticHumansMCF-7 CellsNeovascularization, PathologicReceptors, Vascular Endothelial Growth FactorSilverVascular Endothelial Growth Factor AAngiogenesis InhibitorsAntineoplastic Agentscolloidal silverReceptors, Vascular Endothelial Growth FactorSilverVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID31432795
PMCPMC8676197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.